ACM Research: Why This Chinese Chip Stock Is Just Getting Started

ACM Research (ACMR) experienced a sharp post-earnings decline in August, but quickly reversed course to new highs, extending its nearly 98% year-to-date gain. This rebound, despite a minor revenue miss, was fueled by robust Non-GAAP EPS and gross margins, alongside management's confident reaffirmation of full-year guidance and a significant increase in its long-term China revenue target from $1.5 billion to $2.5 billion. The rally reflects investor recognition of ACM's strategic positioning as a domestic champion benefiting from China's semiconductor independence drive amidst U.S. export controls, complemented by its global expansion efforts, with its P/S of 2.18 suggesting a reasonable valuation for its durable growth story.

Analysis

ACM Research (ACMR) demonstrated a significant market re-evaluation in August, transforming a double-digit, post-earnings stock decline into a rally to new highs, contributing to a near 98% year-to-date gain. The initial sell-off was a knee-jerk reaction to a second-quarter revenue figure of $215.4 million, which was slightly below the consensus estimate of $223.4 million. However, institutional focus quickly shifted to superior underlying fundamentals and a powerfully bullish outlook. The company delivered a substantial profitability beat with non-GAAP EPS of 54 cents, nearly 30% above the 42-cent analyst estimate, supported by a robust non-GAAP gross margin of 48.7% that surpassed its own long-term target range of 40-45%. The primary catalyst for the reversal was management's forward guidance, which included a confident reaffirmation of its full-year 2025 revenue forecast of $850 million to $950 million, and more critically, a nearly 70% increase in its long-term revenue target for Mainland China from $1.5 billion to $2.5 billion. This upgraded outlook is directly anchored to geopolitical tailwinds, as U.S. export controls accelerate China's imperative for semiconductor supply chain localization, positioning Shanghai-based ACMR as a key domestic beneficiary. Despite its strong performance, the stock trades at a price-to-sales ratio of approximately 2.18, suggesting its valuation may not yet fully capture this expanded growth narrative, which is further diversified by strategic expansion into the U.S. market.

Key Decisions for Investors

• Investors should look past the headline quarterly revenue miss and focus on the company's enhanced long-term growth trajectory, driven by the upwardly revised $2.5 billion revenue target for China.
• Given the price-to-sales ratio of 2.18 is presented as reasonable, consider the stock a direct and strategically sound play on the multi-year theme of China's semiconductor independence.
• Monitor execution against the reaffirmed full-year 2025 revenue guidance, as continued delivery will be crucial to validating that the Q2 revenue variance was purely a timing issue.
• Keep an eye on progress with the company's U.S. expansion, including its Oregon facility and customer deliveries, as this provides a key avenue for geographic diversification and mitigates geopolitical concentration risk.